Friday, September 19, 2014

Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 96 Issue 4

If you are unable to see the message below, click here to view.
Clinical Pharmacology & Therapeutics

Advertisement
Multiplexed Immunoassay Services for Oncology Research
 
Myriad RBM's quantitative immunoassays measure nearly 130 cancer-related proteins which can help researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring.

Explore the utility of our service products and learn how your colleagues have successfully applied our protein biomarker solutions to advance their oncology research.

Download Myriad RBM's Oncology Application Notes

TABLE OF CONTENTS

Volume 96, Issue 4 (October 2014)

In this issue
In This Issue
Editorial
News & Views
Perspectives
CPIC Update
Clinical Trial
State of the Art
Review
Research
Sign up for e-alerts Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

In This Issue

Top

In This Issue

Clin Pharmacol Ther 2014 96: 399; 10.1038/clpt.2014.161

Full Text

Editorial

Top

Inflammation: The Dynamic Force of Health and Disease

V Vassileva and M Piquette-Miller

Clin Pharmacol Ther 2014 96: 401-405; 10.1038/clpt.2014.150

Abstract | Full Text

News & Views

Top

HIGHLIGHTS

Highlights

Clin Pharmacol Ther 2014 96: 406-407; 10.1038/clpt.2014.160

Full Text

ASCPT NEWS

ASCPT News

Clin Pharmacol Ther 2014 96: 408-411; 10.1038/clpt.2014.157

Full Text

Perspectives

Top

POINT-COUNTERPOINT

Impact of Modeling and Simulation: Myth or Fact?

S R B Allerheiligen

Clin Pharmacol Ther 2014 96: 413-415; 10.1038/clpt.2014.122

Full Text

What Happened to the Modeling and Simulation Revolution?

P L Bonate

Clin Pharmacol Ther 2014 96: 416-417; 10.1038/clpt.2014.123

Full Text

COMMENTARY

Human Endotoxin Administration as an Experimental Model in Drug Development

A F Suffredini and R J Noveck

Clin Pharmacol Ther 2014 96: 418-422; 10.1038/clpt.2014.146

Abstract | Full Text

CPIC Update

Top

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius and M Niemi

Clin Pharmacol Ther 2014 96: 423-428; advance online publication, June 11, 2014; 10.1038/clpt.2014.125

Abstract | Full Text

Clinical Trial

Top

Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents

D Gonzalez, C Melloni, R Yogev, B B Poindexter, S R Mendley, P Delmore, J E Sullivan, J Autmizguine, A Lewandowski, B Harper, K M Watt, K C Lewis, E V Capparelli, D K Benjamin, Jr and M Cohen-Wolkowiez on behalf of the Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee

Clin Pharmacol Ther 2014 96: 429-437; advance online publication, June 20, 2014; 10.1038/clpt.2014.134

Abstract | Full Text

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

T W Felton, K McCalman, I Malagon, B Isalska, S Whalley, J Goodwin, A M Bentley and W W Hope

Clin Pharmacol Ther 2014 96: 438-448; advance online publication, June 13, 2014; 10.1038/clpt.2014.131

Abstract | Full Text

State of the Art

Top

Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents

R Donald Harvey and E T Morgan

Clin Pharmacol Ther 2014 96: 449-457; advance online publication, July 2, 2014; 10.1038/clpt.2014.143

Abstract | Full Text

Obesity and Resistance to Cancer Chemotherapy: Interacting Roles of Inflammation and Metabolic Dysregulation

L M Lashinger, E L Rossi and S D Hursting

Clin Pharmacol Ther 2014 96: 458-463; advance online publication, June 24, 2014; 10.1038/clpt.2014.136

Abstract | Full Text

Review

Top

Longitudinal Inflammation, Cognitive Decline, and Alzheimer’s Disease: A Mini-Review

B M Bettcher and J H Kramer

Clin Pharmacol Ther 2014 96: 464-469; advance online publication, July 10, 2014; 10.1038/clpt.2014.147

Abstract | Full Text

Phenotype Standardization for Statin-Induced Myotoxicity OPEN

A Alfirevic, D Neely, J Armitage, H Chinoy, R G Cooper, R Laaksonen, D F Carr, K M Bloch, J Fahy, A Hanson, Q-Y Yue, M Wadelius, A H Maitland-van Der Zee, D Voora, B M Psaty, C N A Palmer and M Pirmohamed

Clin Pharmacol Ther 2014 96: 470-476; advance online publication, June 4, 2014; 10.1038/clpt.2014.121

Abstract | Full Text

Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System OPEN

M Wadelius, S E Marshall, G Islander, L Nordang, M Karawajczyk, Q-Y Yue, I Terreehorst, E V Baranova, S Hugosson, K Sköldefors, M Pirmohamed, A-H Maitland-van der Zee, A Alfirevic, P Hallberg and C N A Palmer

Clin Pharmacol Ther 2014 96: 477-481; advance online publication, June 24, 2014; 10.1038/clpt.2014.138

Abstract | Full Text

Research

Top

ARTICLES

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems

L J Rasmussen-Torvik, S C Stallings, A S Gordon, B Almoguera, M A Basford, S J Bielinski, A Brautbar, M H Brilliant, D S Carrell, J J Connolly, D R Crosslin, K F Doheny, C J Gallego, O Gottesman, D S Kim, K A Leppig, R Li, S Lin, S Manzi, A R Mejia, J A Pacheco, V Pan, J Pathak, C L Perry, J F Peterson, C A Prows, J Ralston, L V Rasmussen, M D Ritchie, S Sadhasivam, S A Scott, M Smith, A Vega, A A Vinks, S Volpi, W A Wolf, E Bottinger, R L Chisholm, C G Chute, J L Haines, J B Harley, B Keating, I A Holm, I J Kullo, G P Jarvik, E B Larson, T Manolio, C A McCarty, D A Nickerson, S E Scherer, M S Williams, D M Roden and J C Denny

Clin Pharmacol Ther 2014 96: 482-489; advance online publication, June 24, 2014; 10.1038/clpt.2014.137

Abstract | Full Text

Antipsychotics and Associated Risk of Out-of-Hospital Cardiac Arrest

P Weeke, A Jensen, F Folke, G H Gislason, J B Olesen, E L Fosbøl, M Wissenberg, F K Lippert, E F Christensen, S L Nielsen, E Holm, J K Kanters, H E Poulsen, L Køber and C Torp-Pedersen

Clin Pharmacol Ther 2014 96: 490-497; advance online publication, June 24, 2014; 10.1038/clpt.2014.139

Abstract | Full Text

Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions

A Tornio, A M Filppula, O Kailari, M Neuvonen, T H Nyrönen, T Tapaninen, P J Neuvonen, M Niemi and J T Backman

Clin Pharmacol Ther 2014 96: 498-507; advance online publication, June 27, 2014; 10.1038/clpt.2014.141

Abstract | Full Text

Exposure to Mycophenolic Acid Better Predicts Immunosuppressive Efficacy Than Exposure to Calcineurin Inhibitors in Renal Transplant Patients

Z Daher Abdi, A Prémaud, M Essig, S Alain, E Munteanu, F Garnier, Y Le Meur, P Marquet and A Rousseau

Clin Pharmacol Ther 2014 96: 508-515; advance online publication, June 26, 2014; 10.1038/clpt.2014.140

Abstract | Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: